Exploration of glycosylated-organotin(IV) complexes as anticancer drug candidates

The design of metal-based chemotherapeutic drugs depends on choice of ligand framework, therefore, metals incorporated in a bioactive ligand scaffold hold promise for the improved pharmacokinetic profile and better efficacy of drugs. In this context, glycosylated-organotin(IV) antitumor agents are attractive and prove the state-of-the-art design for chemotherapy due to organotin-induced cytotoxicity. In recent years, many organotin(IV) complexes...